Investing Profile

Elizabeth Douville

InvestorVCFounder
General Partner at AgeChem
Photo of Elizabeth Douville, General Partner at AgeChem

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
McGill University Network
108 CONNECTIONS
HEC Montréal Network
18 CONNECTIONS
HEC Montréal Network
18 CONNECTIONS
HEC Montréal Network
18 CONNECTIONS
University of Ottawa / Université d'Ottawa Network
12 CONNECTIONS
cb
AgeChem General Partner
$100K - $5.0M
$1.5M
5
CompanyStageDateRound SizeTotal Raised
Inversago Pharma
Series COct 2022$69M
Series BSep 2020$35M
Series AJul 2018$7M
$110M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Nanna Luneborg (Forbion), Marco Boorsma (Forbion)
Semathera
Series UnknownMar 2018$3M
$3M
Alethia BioTherapeutics
Series ASep 2010$9M
$16M
Co-investors: Ela Borenstein (Kauffman Fellows)
Board Member BIOQuebecPresent
Board Member BioCanRxPresent
Board Member Genome CanadaPresent
Member Canada Foundation for Innovation/Fondation canadienne pour l'innovationPresent
Board Member Corbin Therapeutics IncPresent
Board Observer Inversago PharmaPresent
Chair Genome CanadaPresent
Board Member SemaThera IncPresent
Vice President Corporate Development Centre de production de produits biologiques (CPPB) inc. / Biologics Manufacturing Centre (BMC) Inc.Present
General Partner AgeChemPresent
Founder AmorChemPresent
President & CEO IRICoRPresent
McGill University Bachelor Biochemistry
HEC Montréal Bachelor Biochemistry
University of Ottawa / Université d'Ottawa PhD Biochemistry
HEC Montréal Postdoctoral internship Signal Transduction
Imperial Cancer Research Fund Postdoctoral internship Signal Transduction
HEC Montréal CIREM-HEC Certificate Executive Program
Institute of Corporate Directors ICD-Rotman, Directors Education Program Directors Education Program